Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome

TY - JOUR

T1 - Antiaggregant and anticoagulant therapy in systemic lupus erythematosus and Hughes' syndrome

AU - Ruiz-Irastorza, G

AU - Khamashta, M A

AU - Hughes, G R V

PY - 2001

Y1 - 2001

N2 - Antiaggregant and anticoagulant drugs are essential in the management of the manifestations due to antiphospholipid syndrome (APS) in patients with primary Hughes' syndrome or systemic lupus erythematosus. Coumadin derivatives (warfarin and acenocumarol), heparin and aspirin are used for secondary thromboprophylaxis and treatment of recurrent miscarriage. The available evidence for each indication is reviewed in this paper. There is still debate regarding the optimal intensity of oral anticoagulation, the best drug combination for pregnancy failure in APS and the management of asymptomatic patients with antiphospholipid antibodies.

AB - Antiaggregant and anticoagulant drugs are essential in the management of the manifestations due to antiphospholipid syndrome (APS) in patients with primary Hughes' syndrome or systemic lupus erythematosus. Coumadin derivatives (warfarin and acenocumarol), heparin and aspirin are used for secondary thromboprophylaxis and treatment of recurrent miscarriage. The available evidence for each indication is reviewed in this paper. There is still debate regarding the optimal intensity of oral anticoagulation, the best drug combination for pregnancy failure in APS and the management of asymptomatic patients with antiphospholipid antibodies.

M3 - Literature review

VL - 10

SP - 241

EP - 245

JO - Lupus

JF - Lupus

IS - 3

ER -